Researchers at the University of Nottingham have made a groundbreaking discovery in the field of cancer treatment. They have developed what is believed to be the first “quantum therapeutic” treatment, which has the ability to target and kill cancer cells in hard-to-treat brain tumors.
This new treatment utilizes the principles of quantum biology, harnessing the power of electrons to induce cell death in cancer cells. The researchers coated gold nanoparticles with specialized molecules, creating bio-nanoantennae, which can deliver targeted electrical stimulation to the cancer cells.
The study, published in Nature Nanotechnology, demonstrated the ability of the bio-nanoantennae to target glioblastoma cells, a particularly aggressive form of brain cancer, without harming healthy cells. The precision of this treatment was described as unprecedented, and it offers hope for effectively treating a cancer with a low survival rate and limited treatment options.
The team of researchers, led by Associate Professor Frankie Rawson, is optimistic about the potential of quantum therapeutics. Dr. Ruman Rahman, from the University of Nottingham’s School of Medicine, emphasized the significance of this research, stating that it brings us one step closer to a new treatment paradigm for disease.
This breakthrough has attracted additional funding and the team is now working on developing a safe clinical application for human use. If successful, this quantum therapeutic treatment could revolutionize cancer treatment and offer new hope for patients facing hard-to-treat tumors.
Sources:
– University of Nottingham press release
– Study published in Nature Nanotechnology